$5.10 $0.08 per serving
Product analysis
Ginkgo Biloba offers a straightforward option aimed at attention and cognitive support, with mixed evidence for everyday concentration. Its unspecified preparation makes a dependable benefit harder to predict.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
Ginkgo quality remains uncertain because its form is unspecified. That limits comparison between preparations.
Ingredient Transparency63
The ginkgo amount is disclosed, allowing comparison of serving sizes. Its preparation is unspecified, limiting comparison with particular extracts.
Value For Money40
Ginkgo value for money cannot be confidently determined. A clear cost recommendation would need a better matched comparison of preparations.
Customer Satisfaction89
Customer ratings are favorable across a large review base. That supplies broad satisfaction feedback without showing that concentration or memory improves.
Product Focus58
One ingredient keeps the formula focused on related cognitive aims. Mixed attention findings call for modest expectations for everyday mental performance.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.08
- Customer rating
- 4.7 · 7,533 ratings
Goals
Impact
Moderate effect
Ginkgo at 125 mg provides the main connection to cognition-related research. The supplied long-term findings did not show slower cognitive decline, so broad maintenance or prevention claims would go beyond the evidence.
How this product is rated for Brain Health
Ingredient fit94
The saved findings identify 1 relevant ingredients and no other active ingredients. The saved findings show strong alignment of disclosed amounts with the comparison amounts.
Goal fit
The saved findings identify 1 relevant ingredients and no other active ingredients.
Dose adequacy
The saved findings show strong alignment of disclosed amounts with the comparison amounts.
Pathways43
The strongest identified area is Cerebral energy metabolism. 1 of 3 areas reach the saved coverage threshold: Cerebral energy metabolism.
Depth
The strongest identified area is Cerebral energy metabolism.
Breadth
1 of 3 areas reach the saved coverage threshold: Cerebral energy metabolism.
Evidence58
Ginkgo provides the strongest eligible evidence contribution in the saved findings. The saved findings match the eligible preparations to studied preparations.
Evidence strength
Ginkgo provides the strongest eligible evidence contribution in the saved findings.
Studied preparation
The saved findings match the eligible preparations to studied preparations.
Formulation logic100
The assessed ingredients can work alone or have their identified partner present. No matched ingredient conflict was recorded. 1 of 1 assessed ingredients reach the saved minimum comparison amount.
Partner coverage
The assessed ingredients can work alone or have their identified partner present.
Conflicts
No matched ingredient conflict was recorded.
Effective doses
1 of 1 assessed ingredients reach the saved minimum comparison amount.
Impact
Moderate effect
Ginkgo has preliminary relevance to selected acute attention-speed tasks and is associated with cerebral blood-flow mechanisms. The 125 mg material is not identified as the studied preparation, so it offers limited support for predicting a cognitive benefit.
How this product is rated for Cognitive Support
Ingredient fit94
Ginkgo gives a focused composition and matches the saved exposure reference.
Goal fit
Ginkgo gives a focused composition and matches the saved exposure reference..
Dose adequacy
The 125 mg ginkgo meets the full saved exposure reference.
Pathways40
Cerebral blood flow is the main area represented in the saved findings. One core area reaches meaningful coverage, giving narrow breadth.
Depth
Cerebral blood flow is the main area represented in the saved findings.
Breadth
One core area reaches meaningful coverage, giving narrow breadth.
Evidence25
Ginkgo supplies preliminary acute-task evidence with limited confidence for unidentified material. The relevant material is not identified as a studied cognitive preparation.
Evidence strength
Ginkgo supplies preliminary acute-task evidence with limited confidence for unidentified material.
Studied preparation
The relevant material is not identified as a studied cognitive preparation.
Formulation logic100
The relevant ingredients can contribute without an additional required partner. All ingredients counted in the saved effective-exposure finding reach its minimum level.
Partner coverage
The saved assessment finds no missing required partner for the relevant ingredients.
Conflicts
No listed cognitive-performance conflict was found in the supplied assessment.
Effective doses
All ingredients counted in the saved effective-exposure finding reach its minimum level.
Impact
Moderate effect
Ginkgo provides 125 mg per serving and has a possible connection to memory and attention. The supplied evidence is mixed, so a reliable improvement in everyday work should not be assumed.
How this product is rated for Productivity Boost
Ingredient fit94
The relevant ingredients are the main focus of the formula. The declared amounts meet the saved comparison's full amount benchmarks.
Goal fit
The relevant ingredients are the main focus of the formula.
Dose adequacy
The declared amounts meet the saved comparison's full amount benchmarks.
Pathways13
The strongest connection is to coping with stress and mental fatigue. The findings do not show broad support across several distinct aspects of productivity.
Depth
The strongest connection is to coping with stress and mental fatigue.
Breadth
The findings do not show broad support across several distinct aspects of productivity.
Evidence53
Ginkgo provides the strongest evidence contribution in the saved findings, with the scope and limitations of its supplied evidence retained. The saved findings recognize the relevant preparations at the assessed amounts.
Evidence strength
Ginkgo provides the strongest evidence contribution in the saved findings, with the scope and limitations of its supplied evidence retained.
Studied preparation
The saved findings recognize the relevant preparations at the assessed amounts.
Formulation logic100
No listed formulation conflict was matched in the saved findings. All ingredients counted in this finding meet the saved minimum amount benchmark.
Partner coverage
The relevant ingredients can contribute without a missing required partner.
Conflicts
No listed formulation conflict was matched in the saved findings.
Effective doses
All ingredients counted in this finding meet the saved minimum amount benchmark.
Impact
Moderate effect
Ginkgo is used for cognitive support, but evidence for attention is mixed. The declared 125 mg is fully recognized in the saved dose assessment; the supplied evidence still calls for modest expectations for everyday concentration.
How this product is rated for Mental Focus
Ingredient fit94
The assessed ingredients are closely centered on cognitive support, although the formula is also linked to other goals. The amounts of the ingredients included in the saved assessment fully meet its dose benchmarks.
Goal fit
The assessed ingredients are closely centered on cognitive support, although the formula is also linked to other goals.
Dose adequacy
The amounts of the ingredients included in the saved assessment fully meet its dose benchmarks.
Pathways44
Support associated with cerebral energy supply is the strongest mechanism in the saved findings. One of the three target mechanisms reaches the saved coverage threshold, so coverage remains concentrated in one area.
Depth
Support associated with cerebral energy supply is the strongest mechanism in the saved findings.
Breadth
One of the three target mechanisms reaches the saved coverage threshold, so coverage remains concentrated in one area.
Evidence62
Ginkgo provides the strongest saved evidence rating here, although attention findings are mixed. The saved assessment recognizes the preparations of all ingredients included at qualifying amounts.
Evidence strength
Ginkgo provides the strongest saved evidence rating here, although attention findings are mixed.
Studied preparation
The saved assessment recognizes the preparations of all ingredients included at qualifying amounts.
Formulation logic100
The saved findings identify no missing required partner for the included ingredients. No configured ingredient conflict was found in the saved assessment. All ingredients included in this finding reach the saved minimum dose threshold.
Partner coverage
The saved findings identify no missing required partner for the included ingredients.
Conflicts
No configured ingredient conflict was found in the saved assessment.
Effective doses
All ingredients included in this finding reach the saved minimum dose threshold.
Impact
Moderate effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Ginkgo Biloba leaves 4:1 extract | 125 mg |
Ginkgo · 125 mg OverallScore57
A serving provides 125 mg of ginkgo extract, though its value for ginkgo is unclear because no value comparison is available. Its flavone and terpene percentages are unknown, and no ginkgolic acid limit is available.
How this ingredient is rated
Composition and Label Disclosure14
The available information lacks flavone and terpene percentages and a ginkgolic acid limit. The extract ratio is 4:1.
Marker and Preparation Disclosure
The available information doesn't state flavone or terpene percentages. The extract ratio is 4:1.
Declared Ginkgolic Acid Limit
The available information does not state a ginkgolic acid limit.
Composition and Label Disclosure100
The serving lists 125 mg of ginkgo extract.
Individual Preparation Amount Disclosure
The serving lists 125 mg of ginkgo extract.
Commercial Price and Usability
A value comparison for ginkgo is unavailable.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
- Ginkgo biloba in the Aging Process: A Narrative Review.
- [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].